Citation 86990

KURODA,M: MIMAKI,Y: HASEGAWA,F: YOKOSUKA,A: SASHIDA,Y: SAKAGAMI,H:. (2001). STEROIDAL GLYCOSIDES FROM THE BULBS OF CAMASSIA LEICHELINII AND THEIR CYTOTOXIC ACTIVITIES.. 49(6)

Citation Details

Title	STEROIDAL GLYCOSIDES FROM THE BULBS OF CAMASSIA LEICHELINII AND THEIR CYTOTOXIC ACTIVITIES.
Authors	KURODA,M: MIMAKI,Y: HASEGAWA,F: YOKOSUKA,A: SASHIDA,Y: SAKAGAMI,H:
Year	2001
Volume	49
Issue	6

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Camassia leichtlinii (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SPIROSTAN-3-BETA-OL,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,5-ALPHA: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	WEAK ACTIVITY
4	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	None
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	WEAK ACTIVITY
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-3-BETA-OL,5-ALPHA: 15-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,5-ALPHA: 15-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	WEAK ACTIVITY
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,5-ALPHA: 15-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	EQUIVOCAL
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	ACTIVE
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-3-BETA-OL,5-ALPHA: 15-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	None
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,5-ALPHA: 15-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	WEAK ACTIVITY
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,5-ALPHA: 15-ALPHA-HYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	WEAK ACTIVITY
16	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-3-BETA-OL,5-ALPHA: 12-BETA-HYDROXY: 3-O-BETA-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	None
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,5-ALPHA: 12-BETA-HYDROXY: 3-O-BETA-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	WEAK ACTIVITY
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,5-ALPHA: 12-BETA-HYDROXY: 3-O-BETA-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE 25(R):	WEAK ACTIVITY
19	Not specified	ABSOLUTE CONFIGURATION DETERMINEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	SPIROSTAN-12-ONE,5-ALPHA: 15-ALPHA-HYDROXY: 3-BETA-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 15-ALPHA-HYDROXY: 3-BETA-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	EQUIVOCAL
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 15-ALPHA-HYDROXY: 3-BETA-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	EQUIVOCAL
22	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FUROSTAN-26-OL-BETA-D-GLUCOPYRANOSIDE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-22-XI-METHOXY:	None
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTAN-26-OL-BETA-D-GLUCOPYRANOSIDE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-22-XI-METHOXY:	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTAN-26-OL-BETA-D-GLUCOPYRANOSIDE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL(1-2)-[O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]-22-XI-METHOXY:	EQUIVOCAL
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-GLUCOPYRANOSIDE 25(R):	None
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-GLUCOPYRANOSIDE 25(R):	INACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-GLUCOPYRANOSIDE 25(R):	INACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE 25(R):	None
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE 25(R):	INACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE 25(R):	INACTIVE
31	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-XYLOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE 25(R):	None
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-XYLOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE 25(R):	INACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-6-ALPHA-OL,5-ALPHA: 3-BETA-HYDROXY: O-BETA-D-XYLOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE 25(R):	INACTIVE
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHOLEST-5-EN-23-ENE,16-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-7-BETA-DIHYDROXY:	None
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHOLEST-5-EN-23-ENE,16-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-7-BETA-DIHYDROXY:	INACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHOLEST-5-EN-23-ENE,16-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-7-BETA-DIHYDROXY:	INACTIVE

Citation 86990

Citation Details

Summary

Organisms and Their Experiments (1)

Camassia leichtlinii (LILIACEAE)

Show SPARQL Queries (1)

Query 1